VOYA Investment Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.7K | Hold |
16,089
| – | – | ﹤0.01% | 2301 |
|
|
2025
Q4 | $33K | Hold |
16,089
| – | – | ﹤0.01% | 2373 |
|
|
2025
Q3 | $55.8K | Sell |
16,089
-8,914
| -36% | -$24.9K | ﹤0.01% | 2375 |
|
|
2025
Q2 | $55K | Buy |
25,003
+457
| +2% | +$748 | ﹤0.01% | 2588 |
|
|
2025
Q1 | $28.5K | Sell |
24,546
-1,779
| -7% | -$2.62K | ﹤0.01% | 2598 |
|
|
2024
Q4 | $33.4K | Sell |
26,325
-1,936
| -7% | -$4.93K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $96.4K | Buy |
28,261
+311
| +1% | +$1.35K | ﹤0.01% | 2669 |
|
|
2024
Q2 | $131K | Buy |
27,950
+545
| +2% | +$3.07K | ﹤0.01% | 2602 |
|
|
2024
Q1 | $203K | Sell |
27,405
-5,447
| -17% | -$45.3K | ﹤0.01% | 2451 |
|
|
2023
Q4 | $333K | Sell |
32,852
-662
| -2% | -$5.81K | ﹤0.01% | 2287 |
|
|
2023
Q3 | $261K | Buy |
33,514
+6,064
| +22% | +$52K | ﹤0.01% | 2382 |
|
|
2023
Q2 | $226K | Buy |
27,450
+824
| +3% | +$7.18K | ﹤0.01% | 2527 |
|
|
2023
Q1 | $193K | Hold |
26,626
| – | – | ﹤0.01% | 2555 |
|
|
2022
Q4 | $236K | Hold |
26,626
| – | – | ﹤0.01% | 2481 |
|
|
2022
Q3 | $326K | Hold |
26,626
| – | – | ﹤0.01% | 2298 |
|
|
2022
Q2 | $315K | Hold |
26,626
| – | – | ﹤0.01% | 2143 |
|
|
2022
Q1 | $506K | Sell |
26,626
-328
| -1% | -$6.1K | ﹤0.01% | 1911 |
|
|
2021
Q4 | $716K | Buy |
26,954
+447
| +2% | +$15.4K | ﹤0.01% | 1772 |
|
|
2021
Q3 | $1.09M | Sell |
26,507
-623
| -2% | -$34.1K | ﹤0.01% | 1504 |
|
|
2021
Q2 | $1.54M | Sell |
27,130
-2,172
| -7% | -$80.2K | ﹤0.01% | 1343 |
|
|
2021
Q1 | $1.23M | Buy |
29,302
+2,082
| +8% | +$119K | ﹤0.01% | 1454 |
|
|
2020
Q4 | $1.91M | Buy |
27,220
+6,400
| +31% | +$263K | ﹤0.01% | 1169 |
|
|
2020
Q3 | $584K | Buy |
20,820
+1,564
| +8% | +$50.9K | ﹤0.01% | 1584 |
|
|
2020
Q2 | $570K | Sell |
19,256
-6,480
| -25% | -$169K | ﹤0.01% | 1585 |
|
|
2020
Q1 | $510K | Buy |
25,736
+618
| +2% | +$15.6K | ﹤0.01% | 1618 |
|
|
2019
Q4 | $744K | Buy |
25,118
+5,658
| +29% | +$141K | ﹤0.01% | 1637 |
|
|
2019
Q3 | $443K | Hold |
19,460
| – | – | ﹤0.01% | 1837 |
|
|
2019
Q2 | $481K | Buy |
19,460
+468
| +2% | +$11.2K | ﹤0.01% | 1809 |
|
|
2019
Q1 | $464K | Hold |
18,992
| – | – | ﹤0.01% | 1821 |
|
|
2018
Q4 | $432K | Buy |
18,992
+1,143
| +6% | +$31.1K | ﹤0.01% | 1819 |
|
|
2018
Q3 | $568K | Hold |
17,849
| – | – | ﹤0.01% | 1770 |
|
|
2018
Q2 | $640K | Buy |
17,849
+2,110
| +13% | +$74.7K | ﹤0.01% | 1647 |
|
|
2018
Q1 | $522K | Buy |
15,739
+360
| +2% | +$12.8K | ﹤0.01% | 1780 |
|
|
2017
Q4 | $473K | Hold |
15,379
| – | – | ﹤0.01% | 1868 |
|
|
2017
Q3 | $369K | Hold |
15,379
| – | – | ﹤0.01% | 2055 |
|
|
2017
Q2 | $258K | Buy |
+15,379
| New | +$277K | ﹤0.01% | 2256 |
|
Other funds holding EDIT
VCM
VPM
N
OM
VOYA Investment Management's EDIT Position: Q1 2026 in Review
VOYA Investment Management held its Editas Medicine (EDIT) position steady in Q1 2026 at 16,089 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2301.
VOYA Investment Management first reported a position in EDIT in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.91M in Q4 2020. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.
- VOYA Investment Management held 16,089 shares of Editas Medicine worth $39.7K as of Q1 2026.
- VOYA Investment Management left its Editas Medicine share count unchanged in Q1 2026.
- Editas Medicine made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2301 holding.
- VOYA Investment Management first reported a position in Editas Medicine in Q2 2017 and has held it in 36 quarters since.
- VOYA Investment Management's Editas Medicine position peaked at $1.91M in Q4 2020.
- 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.